Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2019 Jan 29;73(3):251-260.
doi: 10.1016/j.jacc.2018.10.065.

Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain

James L Januzzi Jr  1 , Sunil Suchindran  2 , Udo Hoffmann  3 , Manesh R Patel  4 , Maros Ferencik  5 , Adrian Coles  6 , Jean-Claude Tardif  7 , Geoffrey S Ginsburg  8 , Pamela S Douglas  4 ; PROMISE Investigators
Affiliations
Clinical Trial

Single-Molecule hsTnI and Short-Term Risk in Stable Patients With Chest Pain

James L Januzzi Jr et al. J Am Coll Cardiol. .

Erratum in

  • Correction.
    [No authors listed] [No authors listed] J Am Coll Cardiol. 2021 Mar 9;77(9):1269-1274. doi: 10.1016/j.jacc.2021.01.026. J Am Coll Cardiol. 2021. PMID: 33663748 No abstract available.

Abstract

Background: Evaluation of stable symptomatic outpatients with suspected coronary artery disease (CAD) may be challenging because they have a wide range of cardiovascular risk. The role of troponin testing to assist clinical decision making in this setting is unexplored.

Objectives: This study sought to evaluate the prognostic meaning of single-molecule counting high-sensitivity troponin I (hsTnI) (normal range <6 ng/l) among outpatients with stable chest symptoms and suspected CAD.

Methods: Participants with available blood samples in PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) were studied, and hsTnI results were analyzed relative to the primary outcome of death, acute myocardial infarction (MI), or hospitalization for unstable angina by 1 year. The secondary outcome was the composite of cardiovascular death or acute MI.

Results: The study sample consisted of 4,021 participants; 98.6% had measurable hsTnI concentrations. The median hsTnI value was 1.6 ng/l. In upper hsTnI quartiles, patients had higher-risk clinical profiles. Higher hsTnI concentrations were associated with greater event probabilities for death, acute MI, or hospitalization for unstable angina. In multivariable models, hsTnI concentrations independently predicted death, acute MI, or hospitalization for unstable angina (hazard ratio: 1.54 per increase in log-hsTnI interquartile range; p < 0.001) and cardiovascular death or acute MI (hazard ratio: 1.52 per increase in log-hsTnI interquartile range; p < 0.001) and were particularly associated with near-term events, compared with longer follow-up.

Conclusions: In symptomatic outpatients with suspected CAD, higher concentrations of hsTnI within the normal range were associated with heightened near-term risk for death, acute MI, or hospitalization. (Prospective Multicenter Imaging Study for Evaluation of Chest Pain [PROMISE]; NCT01174550).

Keywords: chest pain; stable angina; troponin.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1. Study Flow for the Present Analysis
Of an original 10,003 participants, 4,021 were included. hsTnI = high-sensitivity troponin I; PROMISE = Prospective Multicenter Imaging Study for Evaluation of Chest Pain.
FIGURE 2
FIGURE 2. Cumulative Hazard Curves Depicting Time-to-Events as a Function of hsTnI Quartiles at Presentation
(A) Death, acute myocardial infarction, or hospitalization for unstable angina at 1 year. (B) Cardiovascular death or acute myocardial infarction at 1 year. The insets detail outcomes to 3 years of follow-up. Outcomes are depicted to 12 months; insets demonstrate outcomes through complete follow-up of the PROMISE trial. Q = quartile; other abbreviations as in Figure 1.
CENTRAL ILLUSTRATION
CENTRAL ILLUSTRATION. Previous Data Suggest Concentrations of hsTnI Predict Presence and Severity of Underlying Coronary Artery Disease
In the present analysis, we found that high-sensitivity troponin I (hsTnI) concentrations predicted risk for incident death, myocardial infarction (MI), or hospitalization for unstable angina in a graded fashion. In adjusted analyses, high-sensitivity troponin I represented a strong independent predictor of these outcomes, and did so by predicting earlier rather than later events. These results suggest a possible role for measurement of troponin I using a very highly sensitive assay as a part of an overall strategy for evaluation of stable chest symptoms and possible coronary artery disease.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation 2017;135:e146–603. - PMC - PubMed
    1. Cheng VY, Berman DS, Rozanski A, et al. Performance of the traditional age, sex, and angina typicality-based approach for estimating pretest probability of angiographically significant coronary artery disease in patients undergoing coronary computed tomographic angiography: results from the multinational coronary CT angiography evaluation for clinical outcomes: an international multicenter registry (CONFIRM). Circulation 2011; 124:2423–32. 1–8. - PMC - PubMed
    1. Douglas PS, Hoffmann U, Patel MR, et al. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 2015;372: 1291–300. - PMC - PubMed
    1. Bonaca MP, O’Malley RG, Jarolim P, et al. Serial cardiac troponin measured using a high-sensitivity assay in stable patients with ischemic heart disease. J Am Coll Cardiol 2016;68:322–3. - PubMed
    1. Eisen A, Bonaca MP, Jarolim P, et al. High-sensitivity troponin I in stable patients with atherosclerotic disease in the TRA 2 degrees P - TIMI 50 trial. Clin Chem 2017;63:307–15. - PubMed

Publication types

Associated data